Aug 20, 2026 / 12:00PM GMT
Presentation
Aug 20, 2026 / 12:00PM GMT
=====================
Corporate Participants
=====================
* Sumedh Sunkaraneni
Ascentage Pharma Group International - Investor Relations
* Dajun Yang
Ascentage Pharma Group International - Executive Chairman of the Board, Chief Executive Officer, Co-Founder
* Faical Miyara
Ascentage Pharma Group International - Global Chief Business Officer
* Jim Ziegler
Ascentage Pharma Group International - Chief Commercial Officer
* Veet Misra
Ascentage Pharma Group International - Chief Financial Officer
* Yifan Zhai
Ascentage Pharma Group International - Chief Medical Officer
=====================
Conference Call Participants
=====================
* Brian Cheng
JPMorgan Chase & Co - Analyst
* Biren Amin
Piper Jaffray Inc - Analyst
* Jeet Mukherjee
BTIG LLC - Equity Analyst
* Gregory Renza
Truist Securities - Analyst
* Mayank Mamtani
B. Riley Securities, Inc - Analyst
Ascentage Pharma Group International
(FRA:36X)
€
3.62
-0.10 (-2.69%)
Market Cap: 1.43 Bil
Enterprise Value: 1.46 Bil
PE Ratio: 0
PB Ratio: 20.35
GF Score: 73/100 Half Year 2026 Ascentage Pharma Group International Earnings Presentation Transcript
Aug 20, 2026 / 12:00PM GMT
Release Date Price:
€3.38
(-4.52%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot